-
Mazagon Dock
3,149.70 3,047.00(%) -
Bajaj Finance
8,560.00 6,376.55(%) -
Garden Reach Sh.
1,855.00 890.05(%) -
Reliance Industr
1,411.85 1,608.95(%) -
Cochin Shipyard
1,600.40 1,169.00(%) -
Torrent Pharma.
3,360.00 3,589.95(%) -
Hind.Aeronautics
4,466.00 3,045.95(%) -
Tata Motors
642.00 542.55(%) -
Paras Defence
1,469.00 1,592.75(%) -
Samvardh. Mothe.
132.05 107.30(%) -
Data Pattern
2,459.05 1,350.50(%) -
Varun Beverages
507.45 419.40(%) -
IndusInd Bank
810.40 605.40(%) -
Trent
5,134.00 4,058.45(%) -
Hitachi Energy
14,879.00 16,534.50(%) -
Bharat Electron
312.50 221.00(%) -
ICICI Bank
1,424.00 1,051.50(%) -
HDFC Bank
1,936.40 1,977.95(%) -
Tech Mahindra
1,510.60 1,807.40(%) -
Sonata Software
413.95 762.00(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Strides Pharma Science Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln
- Indian Private
- BSE Code : 16996.0
- ISIN : INE939A01011
-
Today’s Low
648.40 -
Today’s High
674.15

-
Open
666.50 -
Perv Close
663.35 -
52W Low
301.13 -
52W High
760.95
Key Indicators
-
P/E(TTM)
68.04
-
Mar.Cap (₹Cr.)
6,008.09
-
Div & Yield %
0.38
-
Book Value(₹)
381.63
-
Debt-Equity Ratio
-1.73
-
AGM Date
29-Apr-2025
-
EPS
9.59
-
P/E Ratio
68.04
Financials Ratios
-
Debt-Equity Ratio
1.28
-
Mar.Cap (₹Cr.)
6,008.09
-
RONW (%)
0.00
-
ROCE (%)
0.00
Score Board
-
Equity (₹ in Cr.)
92.16
-
BV (₹)
381.60
-
Sales( ₹ in Cr.)
2,153.26
-
NP (in Cr.)
70.86
-
NP Var(%)
237.0
-
Div%
25.0
-
CPS (₹)
16.90
-
EPS (₹)
7.70
-
Traded Value (₹ in Lakhs)
6,014.08
-
52 Week High
760.95
-
52 Week Low
301.13
-
Price BSE
653.0
-
Price NSE
652.00
-
Market Capital( in Cr.)
6,014.08
-
P/C Ratio
38.70
-
P/E Ratio
84.90
-
Price Vs.BV
7.70
-
30-Apr-2025( 07:51)
Hot Pursuit - Strid... - The portfolio consists of liqu...
-
11-Apr-2025( 03:34)
Corporate News - Strid... - Arco Lab, a wholly owned subsi...
-
15-Mar-2025( 03:45)
Corporate News - Strid... - <P>Strides Pharma Global (SPG)...
-
31-Jan-2025( 10:50)
Corporate News - Strid... - Strides Pharma Science announc...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)Particulars(INCOME) | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar | 2019 Mar |
---|---|---|---|---|---|---|
INCOME : | ||||||
Sales Turnover | 2,153.26 | 1,854.50 | 1,979.00 | 1,857.57 | 1,691.93 | 1,537.44 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 2,153.26 | 1,854.50 | 1,979.00 | 1,857.57 | 1,691.93 | 1,537.44 |
Other Income | 72.31 | 84.07 | 123.49 | 117.09 | 93.07 | 114.61 |
Stock Adjustments | -4.62 | -21.04 | -114.26 | 117.53 | 2.88 | 45.52 |
Total Income | 2,220.95 | 1,917.53 | 1,988.23 | 2,092.19 | 1,787.88 | 1,697.57 |
EXPENDITURE : | ||||||
Raw Materials | 1,101.85 | 1,044.57 | 987.26 | 1,106.41 | 894.84 | 924.35 |
Power and Fuel Cost | 53.12 | 45.54 | 43.76 | 45.82 | 44.53 | 39.77 |
Employee Cost | 335.21 | 267.01 | 272.09 | 272.72 | 230.23 | 223.21 |
Other Manufacturing Expenses | 144.83 | 130.03 | 151.87 | 134.86 | 117.43 | 76.00 |
Selling and Administration Expenses | 168.38 | 182.64 | 260.83 | 171.51 | 117.95 | 132.91 |
Miscellaneous Expenses | 95.34 | 80.19 | 72.31 | 84.56 | 85.37 | 55.24 |
Employee Benefit Expenses | 335.21 | 267.01 | 272.09 | 272.72 | 230.23 | 223.21 |
Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Expenses | 1,898.72 | 1,749.98 | 1,788.12 | 1,815.87 | 1,490.35 | 1,451.48 |
Operating Profit | 322.22 | 167.54 | 200.11 | 276.32 | 297.53 | 246.08 |
Interest | 167.93 | 138.68 | 74.24 | 65.34 | 66.84 | 54.09 |
Gross Profit | 154.29 | 28.86 | 125.87 | 210.98 | 230.69 | 191.99 |
Depreciation | 84.67 | 93.62 | 104.37 | 99.34 | 94.24 | 83.00 |
Profit Before Tax | 69.62 | -64.76 | 21.50 | 111.64 | 136.45 | 108.99 |
Current Tax | 0.31 | -49.84 | -169.66 | 33.65 | 18.76 | 0.58 |
Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | 3.82 | -19.60 | 10.98 | -0.26 | -2.59 | -1.96 |
Reported Net Profit | 65.49 | 4.68 | 180.19 | 78.24 | 120.28 | 110.37 |
Extraordinary Items | -5.37 | -16.32 | 4.23 | 3.26 | 3.41 | 3.86 |
Adjusted Net Profit | 70.86 | 21.00 | 175.96 | 74.98 | 116.87 | 106.51 |
Adjustment below Net Profit | 0.00 | 0.00 | 0.00 | 0.00 | -57.25 | -9.30 |
P & L Balance brought forward | 745.57 | 740.89 | 583.13 | 522.80 | 616.08 | 532.93 |
Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Appropriations | 13.55 | 0.00 | 22.43 | 17.91 | 156.30 | 17.91 |
P & L Balance carried down | 797.51 | 745.57 | 740.89 | 583.13 | 522.80 | 616.08 |
Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity Dividend (%) | 25.00 | 15.00 | 0.00 | 25.00 | 140.00 | 30.00 |
Dividend Per Share(Rs) | 2.50 | 1.50 | 0.00 | 2.50 | 14.00 | 3.00 |
Earnings Per Share-Unit Curr | 7.13 | 0.52 | 20.07 | 8.72 | 13.43 | 12.32 |
Earnings Per Share(Adj)-Unit Curr | 3.12 | 0.23 | 8.79 | 3.82 | 5.88 | 5.40 |
Book Value | 387.49 | 380.71 | 379.36 | 362.18 | 352.68 | 363.69 |
Book Value(Adj)-Unit Curr | 169.80 | 166.83 | 166.24 | 158.71 | 154.54 | 159.37 |